Applied Therapeutics APLT

$ 9.82 6.05%

Quarterly report 2024-Q2
added 08-07-2024

Applied Therapeutics Balance Sheet 2011-2024 | APLT

Annual Balance Sheet Applied Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-49.4 M	-15.8 M	-52.6 M	-55.1 M	-16.8 M	-18.7 M	-3.28 M	-	-	-	-	-	-
Long Term Debt	38 K	414 K	891 K	1.33 M	-	-	-	-	-	-	-	-	-
Long Term Debt Current	429 K	477 K	442 K	406 K	356 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	797 K	878 K	891 K	1.33 M	1.68 M	-	6.25 M	-	-	-	-	-	-
Total Current Liabilities	71.2 M	33.4 M	26.5 M	21.2 M	14.1 M	-	-	-	-	-	-	-	-
Total Liabilities	72 M	34.3 M	27.4 M	22.6 M	15.8 M	4.43 M	7.25 M	-	-	-	-	-	-
Deferred Revenue	667 K	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-469 M	-349 M	-266 M	-161 M	-66.8 M	-21.3 M	-4.74 M	-	-	-	-	-	-
Total Assets	54.8 M	38.4 M	89.9 M	105 M	48.4 M	20.2 M	3.29 M	-	-	-	-	-	-
Cash and Cash Equivalents	49.9 M	16.7 M	53.9 M	57.5 M	18.8 M	18.7 M	-	-	-	-	-	-	-
Book Value	-17.1 M	4.06 M	62.5 M	81.9 M	32.6 M	15.8 M	-3.96 M	-	-	-	-	-	-
Total Shareholders Equity	-17.1 M	4.06 M	62.5 M	81.9 M	32.6 M	-19.6 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Applied Therapeutics

	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	30 K	38 K	44 K	170 K	291 K	414 K	536 K	655 K	773 K	891 K	1 M	1.11 M	1.22 M	1.33 M	1.33 M	1.33 M	1.33 M	1.68 M	1.68 M	1.68 M	1.68 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	30 K	797 K	735 K	792 K	825 K	878 K	536 K	655 K	773 K	891 K	1 M	1.11 M	1.22 M	1.33 M	1.33 M	1.33 M	1.33 M	1.68 M	1.68 M	1.68 M	1.68 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	55.4 M	72 M	56.2 M	48 M	34.1 M	34.3 M	47 M	52.4 M	23 M	27.4 M	31.8 M	24.5 M	21 M	22.6 M	22.6 M	22.6 M	22.6 M	15.8 M	15.8 M	15.8 M	15.8 M	4.43 M	4.43 M	4.43 M	4.43 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	333 K	667 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-550 M	-469 M	-431 M	-389 M	-359 M	-349 M	-334 M	-315 M	-289 M	-266 M	-239 M	-211 M	-185 M	-161 M	-161 M	-161 M	-161 M	-66.8 M	-66.8 M	-66.8 M	-66.8 M	-21.3 M	-21.3 M	-21.3 M	-21.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	128 M	54.8 M	45.2 M	43.6 M	30 M	38.4 M	56.7 M	78.2 M	65 M	89.9 M	119 M	137 M	156 M	105 M	105 M	105 M	105 M	48.4 M	48.4 M	48.4 M	48.4 M	20.2 M	20.2 M	20.2 M	20.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	122 M	49.9 M	37.5 M	35.6 M	22.9 M	16.7 M	40.4 M	55.7 M	38.2 M	53.9 M	70.2 M	78.4 M	84.1 M	57.5 M	57.5 M	57.5 M	57.5 M	18.8 M	18.8 M	18.8 M	18.8 M	18.7 M	18.7 M	18.7 M	18.7 M	3.28 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	72.4 M	-17.1 M	-11 M	-4.33 M	-4.07 M	4.06 M	9.63 M	25.8 M	42 M	62.5 M	86.7 M	112 M	135 M	81.9 M	81.9 M	81.9 M	81.9 M	32.6 M	32.6 M	32.6 M	32.6 M	15.8 M	15.8 M	15.8 M	15.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	72.4 M	-17.1 M	-11 M	-4.33 M	-4.07 M	4.06 M	9.63 M	25.8 M	42 M	62.5 M	86.7 M	112 M	135 M	81.9 M	81.9 M	81.9 M	81.9 M	32.6 M	32.6 M	32.6 M	32.6 M	-19.6 M	-19.6 M	-19.6 M	-19.6 M	-3.96 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency